Plain-English translation of NCT07348887 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new approach to radiation therapy for head and neck cancer called daily adaptive radiation therapy. Instead of using the same treatment plan every day, this new method adjusts your radiation dose each day based on small changes in your body's anatomy, with a special focus on protecting your submandibular glands (salivary glands in your lower jaw). The goal is to deliver effective cancer treatment while reducing damage to these glands, which can help you maintain better saliva production and quality of life after treatment.
Radiation therapy for head and neck cancer can damage salivary glands, leading to dry mouth that affects eating, swallowing, and quality of life long after treatment ends. This trial exists to see if personalizing radiation therapy to each patient's daily anatomy can protect these important glands while still effectively treating the cancer.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either standard radiation therapy or the new daily adaptive radiation therapy approach. Before treatment starts, you will have baseline tests including scans, salivary flow measurements, swallowing assessments, and quality-of-life questionnaires. Radiation treatment will take about 7 weeks to complete. You will then return for follow-up visits at 1.5 months, 6 months, 12 months, and 24 months after treatment, repeating similar tests to measure how well your salivary glands are working and how you're feeling.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
Canada